We will be hearing from:

​Dr David Erritzøe, Clinical Director and Deputy Head of Centre for Psychedelic Research and Clinical Senior Lecturer in General Psychiatry in Centres for Neuropsychopharmacology at Imperial.

​David conducts psychopharmacological research, using brain-imaging techniques such as PET and MRI. Since 2009 he has been involved in post-doc imaging research into the neurobiology of addictions and major depression at Imperial. David has been investigating brain mechanisms and therapeutic potential of MDMA, ketamine and classic psychedelics.

​Tara Austin, Campaign Manager at Psilocybin Access Rights, has been a psychedelic medicine advocate since 2015, and co-founded PAR in 2022 to improve therapy access. As a Partner at Ogilvy Behavioural Science Practice, she works with top clients and hosts Nudgestock, a leading behavioural science and creativity festival.

​Max Rangeley, Editor of the Cobden Centre, a British economics think tank founded by Member of Parliament Steve Baker and entrepreneur Toby Baxendale.